/amr-adgo-(ama)/infectiousdiseasetreatmentafghanistan.tmb-1200v.jpg?sfvrsn=cdfc473a_6)
The Growing Threat of Antimicrobial Resistance: A Global Crisis Demanding Urgent Action
Antimicrobial resistance (AMR) – the ability of bacteria, viruses, fungi and parasites to resist the effects of medicines – is no longer a looming threat, but a present and escalating global health crisis.A new report from the World Health Organization (WHO) paints a stark picture: resistance is outpacing medical advancements, jeopardizing decades of progress in treating infectious diseases and threatening the health of families worldwide. This article delves into the current state of AMR, the most concerning pathogens, the challenges in surveillance, and the critical steps needed to combat this growing danger.
A Global Problem, Unequally Distributed
The WHO’s latest data reveals a deeply concerning trend: antimicrobial resistance is widespread and increasing across the globe. While no region is immune, the burden is disproportionately felt in low- and middle-income countries.
* East Asia and the Eastern Mediterranean: These regions report alarmingly high rates of infection with resistant bacteria, with approximately one in three infections showing resistance.
* African Region: The situation is even more dire, with one in five infections demonstrating resistance to available treatments.
* Systemic Weaknesses: Critically, resistance is more prevalent and worsening in areas where healthcare systems lack the capacity for accurate diagnosis and effective treatment of bacterial pathogens.This creates a vicious cycle,where limited resources exacerbate the problem.
“Antimicrobial resistance is outpacing advances in modern medicine,threatening the health of families worldwide,” emphasizes Dr. Tedros Adhanom Ghebreyesus, WHO Director-general. “As countries strengthen their AMR surveillance systems, we must use antibiotics responsibly, and make sure everyone has access to the right medicines, quality-assured diagnostics, and vaccines. Our future also depends on strengthening systems to prevent, diagnose and treat infections and on innovating with next-generation antibiotics and rapid point-of-care molecular tests.”
Gram-Negative Bacteria: the Forefront of the Crisis
The report highlights a particularly worrying trend: the increasing resistance of gram-negative bacteria. These pathogens are becoming increasingly perilous globally, with the heaviest impact falling on nations least equipped to respond.
* E. coli and K. pneumoniae: These two bacteria are leading causes of drug-resistant bloodstream infections, often leading to sepsis, organ failure, and death. Globally, over 40% of E. coli and more than 55% of K. pneumoniae are now resistant to third-generation cephalosporins – typically the first line of defence against these infections. In the African Region, this resistance climbs to over 70%.
* Erosion of Essential Antibiotics: The effectiveness of other crucial antibiotics, including carbapenems and fluoroquinolones, is also diminishing against E. coli, K. pneumoniae,Salmonella,and Acinetobacter. Carbapenem resistance, once a rare occurrence, is becoming increasingly common, forcing clinicians to rely on last-resort antibiotics. These alternatives are frequently enough expensive, tough to obtain, and frequently unavailable in low- and middle-income countries, leaving patients with limited or no treatment options.
Surveillance: A Critical Gap, slowly Closing
Effective surveillance is the cornerstone of any prosperous AMR strategy. The WHO’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) has seen significant progress:
* Increased Participation: Country participation in GLASS has more than quadrupled, rising from 25 countries in 2016 to 104 in 2023.
* Persistent Challenges: Despite this growth, nearly half (48%) of countries did not report data to GLASS in 2023.Moreover, approximately half of those reporting lack the robust systems needed to generate reliable data. This is particularly concerning as the countries facing the greatest AMR challenges are often those with the weakest surveillance capabilities.
The recent United Nations General Assembly political declaration on AMR acknowledges the urgency of the situation and sets targets for strengthening health systems and adopting a ‘One health’ approach – coordinating efforts across human,animal,and environmental health sectors.
The path Forward: A Call to Action
Combating AMR requires a multifaceted, coordinated global response. Key priorities include:
* Strengthening Surveillance: Countries must prioritize investment in laboratory systems and data generation, particularly in underserved areas, to accurately assess their AMR situation and inform treatment guidelines and policies.
* Data Reporting: The WHO calls on all nations to report high-quality AMR and antimicrobial use data to GLASS by 2030. This requires concerted efforts to improve data quality, geographic coverage, and data sharing.
Related reading